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We have developed a protocol suitable for high-throughput lipidomic analysis of human brain 
samples. The traditional Folch extraction (using chloroform and glass-glass homogenisation) 
was compared to a high-throughput method combining methyl-tert-butyl ether (MTBE) 
extraction with mechanical homogenisation utilising ceramic beads. This high-throughput 
method significantly reduced sample handling time and increased efficiency compared to 
glass-glass homogenising. Furthermore, replacing chloroform with MTBE is safer (less 
carcinogenic/toxic), with lipids dissolving in the upper phase, allowing for easier pipetting 
and the potential for automation (i.e. robotics). Both methods were applied to the analysis of 
human occipital cortex. Lipid species (including ceramides, sphingomyelins, choline 
glycerophospholipids, ethanolamine glycerophospholipids and phosphatidylserines) were 
analysed via electrospray ionisation mass spectrometry and sterol species were analysed 
using gas chromatography mass spectrometry. No differences in lipid species composition 
were evident when the lipid extraction protocols were compared, indicating that MTBE 
extraction with mechanical bead homogenisation provides an improved method for the 
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 It is established that lipid metabolism changes profoundly during human brain 
development and ageing (1-2). There is also increasing evidence indicating that neurological 
disorders including Parkinson’s disease (3-4), Alzheimer’s disease (5-6), Huntington’s 
disease (7) and Schizophrenia (8) are all associated with alterations in cerebral lipid 
homeostasis. In the case of Alzheimer’s disease, three of the strongest genetic risk factors for 
the common late-onset form of the disease, i.e. APOE, CLU, ABCA7, are involved in brain 
lipid transport (9-10). This highlights the fact that altered brain lipid metabolism may not 
only be a consequence of the disease process but may in fact represent a causative factor that 
could be amenable to therapeutic targeting. There is clearly a great need to develop efficient 
methods that will facilitate the post-mortem analysis of human brain tissues by high-
throughput lipidomic approaches. Such a method will help to clarify the extent to which 
altered lipid metabolism is associated with various human neurological conditions and may 
aid in the discovery of biomarkers for disease status as well as in monitoring treatment 
efficacy (11). In the present study we aimed to develop an improved method that could 
provide an alternative for the widely used Folch extraction / glass-glass homogenisation 
method. 
Shotgun lipidomics involves the analysis of a crude lipid extract via electrospray 
ionization mass spectrometry (ESI-MS; see (12)). With recent advances in mass 
spectrometry, such as the employment of automated chip-based nanospray technology, the 
bottleneck for modern shotgun lipidomic studies is the time required for traditional lipid 
extraction. A typical lipid extraction usually follows the Folch extraction (13), which 
employs chloroform/methanol (2:1, by vol) and is generally accompanied by glass-glass 
homogenisation. Although this method has become well-established over the last half century 
as one of the most popular lipid extraction techniques, there are some disadvantages, in terms 
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of both safety and efficiency that need to be addressed. In particular, chloroform is highly 
toxic and carcinogenic. Previous lipid studies have solved this toxicity issue to some degree 
by replacing chloroform with dichloromethane (see 14, 15). However, both these solvents are 
very dense, which is inconvenient during lipid extraction, as the lipids will dissolve in the 
lower chloroform layer during phase separation (i.e. difficult to pipette without contamination 
from the aqueous layer and also less compatible with the potential use of robotics). In 
addition to this, glass-glass homogenisation is highly time-consuming and also increases the 
risk of cross-contamination between samples. 
An alternative to traditional glass-glass homogenisation is a new high-throughput 
technology that employs mechanical bead beater homogenisation capable of homogenising 
up to 96 samples within approximately two minutes. The risk of cross-contamination is also 
limited, as single-use disposable tubes containing ceramic beads are used for each sample. 
Variation between operators is also reduced as the mechanical bead homogenisation is 
automated, making results more consistent and reproducible. Previous studies have processed 
normal and diseased human brain tissue for the measurement of fatty acid composition (16-
17), with bead homogenisation results comparable to Potter-Elvehjem homogenisation 
(equivalent to glass-glass). Other metabolomic studies have also employed automated bead 
homogenisation for extraction and quantification of lipids (including glycerophospholipids 
and sphingolipids) from various tissue matrices, including mouse brain, kidney, liver, adipose 
tissue and muscle (18), as well as fish liver (19). However, a direct comparison of the Folch 
glass-glass homogenisation method with a mechanical bead homogenisation has not been 
previously investigated. 
 A recent lipidomic study demonstrated that methyl-tert-butyl ether (MTBE) can 
effectively replace chloroform for the extraction of lipids from tissue matrices (including 
mouse brain, Caenorhabditis elegans eggs and Escherichia coli; see (20)). This MTBE 
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extraction protocol has also been applied to measure lipids in cerebrospinal fluid of 
Alzheimer’s disease patients (21-22). A Bligh and Dyer (23) variation of this MTBE protocol 
has also been utilised in previous lipidomic studies of human plasma (20, 24-26). The main 
advantages of MTBE over chloroform are its lower toxicity and density (so that lipids 
dissolve in the upper layer during phase separation), which greatly improves safety and ease 
of sample processing (see (20) for more details). 
To overcome the aforementioned problems associated with traditional lipid extraction 
techniques, protocol comparisons were made between the well-established Folch extraction 
(using glass-glass homogenisation; i.e. “Glass-Chloroform”) and a modified method that 
employed bead homogenisation (Precellys®24) and, based on (20), replaced chloroform with 
MTBE (i.e. “Bead-MTBE”). The lipid composition of human occipital cortex was measured 
as a test sample. The lipid species measured by ESI-MS included: ceramides (Cer), 
sphingomyelins (CerPCho), choline glycerophospholipids (ChoGpl), ethanolamine 
glycerophospholipids (EtnGpl) and phosphatidylserines (PtdSer). In combination with this 
“shotgun” approach, the lipid extracts of human brain tissue were also subjected to a more 
targeted analysis of sterol species via gas chromatography mass spectrometry (GC-MS). 
 
Materials and Methods 
Materials and internal standards 
MTBE, chloroform, methanol, acetone, hexane and acetonitrile were HPLC grade and 
purchased from Thermo Scientific, Scoresby, VIC, Australia; analytical grade butylated 
hydroxytoluene (BHT) and sodium hydroxide (98% minimum) from Sigma Aldrich, Sydney, 
NSW, Australia; analytical grade ammonium acetate from Crown Scientific, Moorebank, 
NSW, Australia; 15 x 45 mm (4 mL) screw thread vials and 12 x 32 mm (1.8 mL) wide 
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mouth vials (both with PTFE/silicone septa caps) from Grace Davison, Rowville, VIC, 
Australia. All solvents contained 0.01% w/v BHT. 
Two internal standard mixtures were added to each sample. Firstly, 4 µL/mg of tissue 
of the phospholipid/sphingolipid standard mixture containing: 75 µM CerPCho(d18:0/12:0), 
75 µM Cer(d18:1/10:0), 500 µM PtdCho(19:0/19:0),  175 µM PtdSer(17:0/17:0), 225 µM 
PtdEtn(17:0/17:0),  25 µM Lyso PtdCho (17:0) and 25 µM Lyso PtdEtn (14:0) in 
chloroform/methanol (2:1, by vol); Avanti Polar Lipids purchased from Auspep, Tullamarine, 
VIC, Australia. Secondly, 10 µL/sample of sterols standard mixture in ethanol was added, 
including: desmosterol-d6, 14-demethyl-lanosterol-d6, (Avanti Polar Lipids), -sitosterol-d7, 
campesterol-d3 and 7-ketocholesterol-d7 (CDN Isotopes, Quebec, Canada) and 27-
hydroxycholesterol-d5 and 24-hydroxycholestero-d7 (Medical Isotopes, Inc, Pelham, AL, 
USA). Lanosterol, squalene, stigmasterol and 24,25-dihydrolanosterol were quantitated using 
other heavy sterol internal standards. 
 
Human brain tissue 
The human brain tissue was collected with written informed consent as approved by 
the Human Research Ethics Committee of the University of New South Wales (HREC0937) 
in conformity with accepted international standards following the Declaration of Helsinki. 
The use of human brain tissue for this project was approved by the University of Wollongong 
Human Research Ethics Committee (HE10/327). Approximately 1 g of frozen human 
occipital cortex from a neurologically normal male (81 years of age, post-mortem delay 3 
hours) was received from the Sydney Brain Bank (Project # PID0154). The frozen brain 
tissue was pulverised on dry ice and aliquots of approximately 10 mg were accurately 
weighed and stored at -80°C prior to analysis. Each protocol included three replicates (n=3). 
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Additional validation of the lipid extraction protocol was undertaken using frozen 
human anterior cingulate cortex from three neurologically normal males. Ages were 60, 78 
and 88 years with post-mortem delay of 25, 6.5 and 9 hours respectively. 
 
Lipid extraction 
A comparison of the two lipid extraction methods is shown in Figure 1 and each is 
described in detail below. 
Traditional Glass-Chloroform 
This protocol was based on the traditional Folch extraction (13) with modifications 
previously described (see 3, 27, 28). Each 10 mg pulverised brain aliquot was homogenised 
on ice with a glass-glass homogeniser (1mL Tenbroeck Tissue Grinder; Edwards Instrument 
Company, Narellan, NSW, Australia) in 500 µL methanol containing internal standards (plus 
166 µL methanol to rinse homogeniser). The homogenate was transferred to a 4 mL vial and 
1332 µL chloroform added (chloroform/methanol 1:2, by vol). The homogenate was split, 
with 1/3 transferred to a separate 4 mL vial (for phospholipid analysis), while the remaining 
2/3 was used for sphingolipid and sterol analysis. Both fractions were treated equally except 
for the addition of sodium hydroxide (final concentration 0.7M) to the sphingolipid and sterol 
fraction (to promote hydrolysis of phospholipid ester linkages). Following overnight rotation 
at 4°C, 0.15M ammonium acetate was added (chloroform/methanol/0.15M ammonium 
acetate 8:4:3, by vol; 333 µL for sphingolipid/sterols and 167 µL for phospholipids), the 
sample centrifuged (10 minutes at 2000 x g at 4°C) and the chloroform phase (lower phase) 
containing lipids transferred to a new 4 mL vial. Chloroform/methanol (1:2, by vol) was 
added to the original homogenate (equivalent to original volume), centrifuged as above and 
the lower phase combined with the first chloroform extract. A second phase separation was 
performed on this chloroform extract by adding 0.15M ammonium acetate (333 µL for 
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sphingolipid/sterols and 167 µL for phospholipids), centrifuging as above and transferring the 
lower phase to a new 4 mL vial (1.8 mL vial for phospholipid fraction), which was then dried 
under nitrogen at 37°C.  The phospholipid fraction was resuspended in 300 µL 
chloroform/methanol (1:2, by vol). The volume for the sphingolipid and sterol fraction was 
700 µL, with half (350 µL) transferred to a 1.8 mL vial for sphingolipid analysis and the 
remainder (350 µL) used for sterol analysis (see below for derivitisation procedures). All 
phospholipid and sphingolipid extracts were stored at -80°C prior to analysis via ESI-MS. 
Bead-MTBE 
The MTBE extraction was modified from (20) with Precellys®24 settings based on 
previous work (16). Each 10 mg pulverised brain aliquot was weighed directly into a 0.5 mL 
Precellys tube (Sapphire Bioscience, Waterloo, NSW, Australia) and homogenised in 300 µL 
ice-cold methanol containing internal standards, using a Precellys®24 (Bertin Technologies; 
2 x 30 sec at 6000 rpm). After transferring the homogenate to a 4 mL glass vial the Precellys 
tube was rinsed with 162 µL methanol and 1540 µL MTBE added to the glass vial 
(MTBE/methanol 10:3, by vol). The homogenate was split into phospholipids and 
sphingolipid/sterol fractions as described above. Following overnight extraction/hydrolysis, 
0.15M ammonium acetate was added (MTBE/methanol/0.15M ammonium acetate 20:6:5, by 
vol; 253 µL for sphingolipid/sterols and 127 µL for phospholipids), the sample centrifuged 
(as above) and the organic phase (upper phase) collected in a 4 mL vial. The original 
homogenate was re-extracted by addition to the upper phase of MTBE/methanol/0.15M 
ammonium acetate (20:6:5, by vol; 205 µL for sphingolipid/sterols and 411 µL for 
phospholipids), followed by centrifugation and combining the upper phase with the first 
extract. This lipid extract was then dried under nitrogen at 37°C and resuspended in 




Mass spectrometry & lipid analysis settings  
Phospholipid and sphingolipid extracts were analysed via ESI-MS using a hybrid 
triple quadrupole ion trap mass spectrometer (QTRAP® 5500, AB SCIEX, Framingham, 
Massachusetts, USA) and an attached chip-based, automated nanospray source (Triversa 
Nanomate®, Advion, Ithaca, NY, USA). See Table 1 for ESI-MS settings. Prior to 
introduction on the mass spectrometer lipid extracts were diluted 1/50 with 
chloroform/methanol (1:2, by vol) and ammonium acetate was added (final concentration 
5µM). Samples (50 µL) were loaded onto a 96-well plate, sealed with foil and centrifuged for 
10 minutes at 2204 x g (Eppendorf Centrifuge 5430). The spray parameters were set with a 
gas pressure of 0.4 psi and voltage applied at 1.2 and 1.1 kV for positive and negative mode 
respectively. Multi-channel acquisition (MCA) was employed for sphingomyelin and 
ceramide precursor ion scans only.  
  Phospholipid and sphingolipid species were quantified using AB SCIEX Lipidview™ 
Software (Framingham, Massachusetts, USA; see 29). The processing settings for 
Lipidview™ were: mass tolerance 0.5 and minimum % intensity 0 (all species) and minimum 
S/N 50 (Cer, CerPCo, ChoGpl, EtnGpl) or 0 (PtdSer). Head group scans were used to quantify 
each lipid species (see Table 1) and the fatty acyl chain scans were used to determine each 
molecular species (for phospholipids only). Masses that could be assigned to ether or odd-
chain fatty acids were assumed to be ether-linked phospholipids. Where two or more isomeric 
species from the same class were detected the relative proportion of the peak areas from each 
fatty acyl scan was used to calculate the final corrected areas for each molecular species. For 
example, ChoPCo (16:0/18:1) and ChoPCo (18:0/16:1) made up 95 and 5% of total ChoPCo 
34:1 peak areas respectively. Any species < 0.5% of lipid class were removed from the 
analysis. Ether-linked EtnGpl do not produce the neutral loss of 141 Da to the same extent as 
diacyl EtnGpl (30) and previous work in our group has demonstrated that plasmalogens 
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produce the 141 NL at about 29% the efficiency of diacyl EtnGpl (31). As a diacyl internal 
standard was used to quantify all EtnGpl in the present study, an experimentally determined 
correction factor of 3.45 was applied to the ether-linked EtnGpl data (T. Mitchell, unpublished 
data). For ceramide the characteristic ions were [M+H]+ and [M-H2O]
+ for each species. The 
peak areas for both ions were exported from Lipidview™, combined and corrected against the 
combined peak areas from the internal standard. 
 
Sterol derivatisation and GC-MS settings 
The sterol fraction of the lipid extract (from both protocols) was dried down under 
nitrogen at 37°C and the following added: 1.5 mL 0.1M hydrochloric acid, 1.5 mL 80mM 
acetic acid, 250 µL 1M sodium hydroxide and 250 µL methanol (pH of final solution ~ 4.75). 
Solid phase extraction columns (Waters Oasis Max 3cc; Waters, Rydalmere, NSW, Australia) 
were preconditioned with 2 mL methanol and 2 mL 40mM acetate buffer (pH 4.5).  The 
sample was then loaded and washed with 2 mL 30% methanol 40mM formic acid (pH4.5). 
Sterol fractions were eluted with 1.8 mL hexane followed by 1.8 mL acetone/hexane (30:70, 
by vol) and then dried down under nitrogen at 37°C. Samples were then derivatised by the 
addition of 20 µL acetonitrile and 20 µL Selectra-SIL BSTFA (N,O-
bis(trimethylsilyl)trifluoroacetamide) containing 1% TMCS (trimethylchlorosilane; United 
Chemical Technologies, purchased from PM Separations, QLD, Australia) and incubation for 
one hour at 37°C.  
After drying under nitrogen at 37°C and reconstitution in 30 uL toluene, derivatised 
samples were analysed by an Agilent 7000B triple quadrupole mass selective detector 
interfaced with an Agilent 7890A GC system gas chromatograph, equipped with an automatic 
sampler and a computer workstation. The injection port and GC-MS interface were kept at 
280°C. Separations were carried out on a fused silica capillary column (30 m x 0.2 mm i.d.) 
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coated with cross-linked 5% phenylmethylsiloxane (film thickness 0.33µm; Agilent, J and 
W). Helium was the carrier gas with a flow rate of 1.2 ml/min (average velocity = 59 cm/sec).  
Derivatised samples (1 µl) were injected splitless into the GC injection port.  Column 
temperature was increased from 165°C to 270°C at 30°C/min after 1 min at 165°C, then 
temperature was raised to 300°C at 5°C/min and held at 300°C for 4 min.  Selected-reaction 
monitoring was performed using the PCI mode using methane as the reagent gas (4 ml/min), 
Argon as the collision gas (1.5 ml/min) and 2.25 ml/min atomic He in the collision cell to 
reduce chemical noise from metastable He. The ion source was maintained at 280°C and the 




Statistical analysis was performed using JMP 9.0 (SAS Institute Inc., NC, USA). All 
results are expressed as mean ± S.E.M. with p<0.05 set as the level of significance. Data was 
tested for normality using Shapiro-Wilk W test and homogeneity of variance using a 2-sided 
F Test. Student’s t tests were used for comparisons between treatments (Bead-MTBE versus 
Glass-Chloroform) for each lipid species.  
 
Results and Discussion 
Data resulting from the quantification of human occipital cortex lipids that were 
solvent-extracted using either the Glass-Chloroform or Bead-MTBE methods are presented in 
a similar format in all figures. The results for the sphingolipids, Cer and CerPCho, are shown 
in Figure 2 and Figure 3 respectively. The glycerophospholipids, ChoGpl, EtnGpl and 
PtdSer, are shown in Figure 4, Figure 5 and Figure 6 respectively. In each of these figures, 
representative head group spectra from the Bead-MTBE extraction are found in the top panel 
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(a) and the Glass-Chloroform in the middle panel (b). Comparison of these representative 
spectra for each lipid class reveals no obvious difference between the two methods, in terms 
of ions present or the maximum ion intensity (see Figure 2 – 6; “a” versus “b”). This 
indicates that the recovery levels were similar for both methods. 
The lower panel (c) in Figures 2 - 6 show the quantified concentrations for each lipid 
class (nmol/g tissue wet weight). The most abundant lipid species in the human occipital 
cortex was ChoGpl (total~19000 nmol/g tissue), followed by EtnGpl (~8000 nmol/g tissue) 
and PtdSer (~6000 nmol/g tissue), CerPCho (~4000 nmol/g tissue), with much lower levels of 
ceramide present (~600 nmol/g tissue). No significant difference between Bead-MTBE and 
Glass-Chloroform methods was evident for the total levels of each lipid class (p > 0.28). 
Looking in more detail firstly at the sphingolipids, we identified 13 ceramide species 
using both extraction methods (Figure 2c). The most abundant species were Cer(d18:1/18:0) 
and Cer(d18:1/24:1). Only Cer(d18:1/18:0) showed a significant increase (15%) in 
concentration in the Bead-MTBE extraction (p = 0.027). For sphingomyelin, 15 species were 
identified (Figure 3c). The major species present were: CerPCho(d18:1/18:0), 
CerPCho(d18:1/24:1) and CerPCho(d18:1/20:0). No significant difference between extraction 
protocols was evident in the level of any CerPCho species (p > 0.14). 
In terms of the glycerophospholipids, 22 ChoGpl species were present in the human 
occipital cortex (20 diacyl and 2 ether), with ChoGpl(16:0/18:1) and ChoGpl(16:0/16:0) the 
most abundant species (Figure 4c). No difference between the two methods was observed for 
ChoGpl analysis (p > 0.11). A total of 33 EtnGpl species were identified (18 diacyl and 15 
ether species), with EtnGpl(18:0/22:6) by far the most abundant species present (Figure 5c). 
Only EtnGpl(O-16:1/22:5) and EtnGpl(O-18:2/20:4) showed a significant increase (27% 
each) using the Bead-MTBE extraction method (p = 0.022 for both). Ether-linked EtnGpl 
species were present at 35% of total EtnGpl in human occipital cortex. This value 
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corresponds with the plasmalogen levels present in normal human brains in previous studies, 
with values varying from 23% in human anterior cingulate cortex and primary visual cortex 
(3), up to 56% of total EtnGpl in temporal cortex grey matter (32). 
No significant difference between the two protocols was observed for the PtdSer 
analysis (p > 0.38; Figure 6c). Of the 17 PtdSer species quantified, PtdSer(18:0/18:1) and 
PtdSer(18:0/22:6) were present at the highest levels. Results for the lysoglycerophospholipids 
were consistent with their diacyl counterparts, with 12 species of lyso-ChoGpl and 10 species 
of lyso-EtnGpl quantified (results not shown). No significant difference between extraction 
methods was found for lyso-ChoGpl (p > 0.11) or lyso-EtnGpl (p > 0.09). 
Both extraction protocols were also employed in the quantification of sterol species in 
the human occipital cortex (Figure 7). Representative spectra are not shown as the quantified 
values were obtained using targeted multiple reaction monitoring (MRM). No significant 
differences were found for any sterol species when the Bead-MTBE and Glass-Chloroform 
extraction methods were compared (Figure 7). The sterol species identified included 
cholesterol precursors (squalene, lanosterol, 14-demethyl lanosterol, desmosterol and 24,25-
dihydrolanosterol), oxysterols (7keto-cholesterol, 27-hydroxycholesterol and 24-
hydroxycholesterol) and phytosterols (campesterol, stigmasterol and β-sitosterol). Of the 
species identified, 24-hydroxycholesterol was the most highly abundant sterol species present 
in the human occipital cortex which is consistent with previous data (3). As an additional 
measure, total free cholesterol was quantified using ESI-MS (with lathosterol-d4 as an 
internal standard). In the occipital cortex cholesterol mean values were 411 ng/mg wet tissue 
weight (results not shown). No significant difference in cholesterol levels between the two 
protocols was detected (p = 0.6842). 
To further validate the Bead-MTBE extraction method, we compared the sphingolipid 
composition of three different control subjects from a different brain region (anterior 
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cingulate cortex). Sphingomyelin and ceramide levels in human anterior cingulate cortex are 
shown in Figure 8. The sphingolipid species identified were the same as for occipital cortex 
(see Figure 2 and Figure 3). For sphingomyelin, only CerPCho(d18:1/18:1) showed a 
significant increase in concentration in the Bead-MTBE extraction (p = 0.033). Three 
ceramide species demonstrated a significant difference between the two protocols, including 
Cer(d18:1/16:0), Cer(d18:1/22:1) and Cer(d18:1/23:1), with p-values of 0.034, 0.001 and 
0.017 respectively. The sphingolipid species with significant differences between the two 
protocols were all low abundance species. These results are comparable to the single occipital 
cortex sample and demonstrate that there are no major differences between the two methods 
when samples from multiple donors are analysed. 
From these studies we conclude that the high-throughput Bead-MTBE protocol is 
equivalent to the traditional Glass-Chloroform protocol for lipid extraction and quantification 
of glycerophospholipid, sphingolipid and sterol species in human brain tissue. Furthermore, 
the average variation for each lipid class was also similar, with the following coefficient of 
variation (CV) values for Bead-MTBE and Glass-Chloroform respectively: Cer, 20.1% and 
23.3%; CerPCho, 25.3% and 17.0%; ChoGpl, 21.9% and 15.0%; EtnGpl, 21.4% and 13.1%; 
PtdSer, 24.7% and 15.2%; and sterols, 22.4% and 23.5%. The data suggest that the Bead-
MTBE method may be slightly more efficient than the traditional Folch extraction using 
glass-glass homogenisers for lipid extraction. From Figures 2 – 6 it is obvious that there is a 
trend for increased levels of lipids detected using the Bead-MTBE extraction relative to 
Glass-Chloroform extraction, with a significant increase in a small number of lipid molecular 
species for Bead-MTBE (Cer and EtnGpl only). This indicates that lipid recoveries using this 
new extraction method may be improved slightly.  
As mentioned above, we observed significant increases in three lipid species with the 
Bead-MTBE extraction in the present study (p < 0.05). It should be noted, however, that of 
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the total 133 lipid species identified we would expect to find a significant difference for 5% 
of these species by chance alone (i.e. 6 or 7 species). Therefore, with significant differences 
for only three lipid species, we can safely conclude that there was no difference in lipid 
composition results when Bead-MTBE and Glass-Chloroform extraction methods were 
compared. 
We based the MTBE extraction method used in the present study on our own 
modified Folch protocol (see 27, 28), as opposed to the variation of Folch used in (20).  That 
is, we used 0.15M ammonium acetate instead of water for phase separation, as the use of a 
salt should increase the partition coefficient and reduce the loss of lipids in the aqueous phase 
(13). Although brain samples were homogenised in methanol in the current protocol, we also 
tested homogenisation in 0.01% w/v ammonium acetate, followed by extraction with 
MTBE/methanol (as per (20); results not shown). Results were similar to the sphingolipid and 
glycerophospholipid classes quantified using Bead-MTBE and Glass-Chloroform, indicating 
that homogenisation of brain tissue in methanol or 0.01% ammonium acetate is equivalent. 
Based on the knowledge that sulfatides are known to be enriched in the brain (33), we 
also determined the mol% distribution of sulfatide species in human occipital cortex (data not 
shown). A total of 18 sulfatide species were identified. Only two minor species (SGalCer 
41:2;2 and SGalCer 42:3;2) demonstrated a significant increase in the Bead-MTBE extraction 
protocol, indicating that sulfatide brain levels can be accurately determined using the Bead-
MTBE lipid extraction method. 
In addition to the comparison between the Bead–MTBE and Glass–Chloroform 
extraction methods, we also tested the influence of increasing brain tissue amounts on the 
extraction efficiency of MTBE/methanol for the various lipid classes (results not shown). 
Total solvent volume remained constant (~2 mL) while increasing the amount of control 
tissue to be extracted (i.e. 10, 20 and 40 mg). On average the variation between tissue 
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amounts was ≤ 10% for all quantified glycerophospholipids (including ChoGpl, EtnGpl and 
PtdSer), as well as CerPCho. The average variation for ceramide was higher (31%), with 
significantly reduced quantitation levels at 20 and 40 mg tissue mass. The mol% values for 
ceramide species within ceramide class appeared to be consistent, however, indicating that 
the relative species distribution is maintained for up to 40 mg of tissue. This apparent lower 
recovery of ceramide species at higher tissue:solvent ratios may be to due the much lower 
abundance of this lipid class (for example, ChoGpl is present at 33 times the levels of Cer in 
the occipital cortex). Therefore, although 2 mL MTBE/methanol is sufficient for the 
quantification of glycerophospholipids and sphingomyelin in up to 40 mg brain tissue, if 
ceramide is to be included in the analysis we would recommend increasing solvent volumes 
accordingly to avoid under-estimation of this lipid class. 
In summary, lipid profiling of human brain using MTBE extraction and mechanical 
bead homogenisation was comparable to Folch extraction (i.e. chloroform) with glass-glass 
homogenisation. This was true for sphingolipids (ceramide and sphingomyelin), 
glycerophospholipids (choline glycerophospholipids, ethanolamine glycerophospholipids and 
phosphatidylserine) and sterols. This high-throughput Bead-MTBE protocol improves upon 
traditional lipid extraction methods as it is safer and much more efficient. The Bead-MTBE 
protocol is approximately four times quicker than Glass-Chloroform in the homogenisation of 
24 samples (i.e. 1 hour versus 4 hours), with the additional benefit being that tissue aliquots 
can be weighed directly into the Precellys tubes prior to homogenisation (thus reducing 
double-handling times). The lower density of MTBE further enhances the lipid extraction 
procedure (by dissolving lipids in the upper phase) and is also better for the potential 
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Table1: ESI-MS settings for phospholipid and sphingolipid analysis of human brain occipital 
cortex. Scan rate was set at 200 Da/s for all scan types. Precursor ion (PI); neutral loss (NL); 
declustering potential (DP); entrance potential (EP); collision energy (CE); collision cell exit 
potential (CXP). 
Lipid         Ion Mode       Scan Type   DP      EP CE CXP Range    
Head group scans 
Cer +ve PI 264.4 m/z          120 14 35 10  400-700 
CerPCo +ve PI 184.2 m/z          100 12 50 15  600-900 
ChoGpl +ve PI 184.1 m/z           100   10 47  8    450-880 
EtnGpl +ve  NL 141 Da             100   10 30 8  420-830 
PtdSer +ve     NL 185 Da             100 10 30 8  650-830 
Fatty acyl chain scans 
14:0 -ve PI 227.2 m/z        -100 -10 -55   -11 400-900  
16:1 -ve PI 253.2 m/z        -100 -10 -55   -11 600-900  
16:0 -ve PI 255.2 m/z        -100 -10 -55   -11 400-900  
17:0 -ve PI 269.3 m/z        -100 -10 -55   -11 560-900  
18:3 -ve PI 277.2 m/z        -100 -10 -55   -11 600-900  
18:2 -ve PI 279.2 m/z        -100 -10 -55   -11 600-900  
18:1 -ve PI 281.3 m/z        -100 -10 -55   -11 600-900  
18:0 -ve PI 283.3 m/z        -100 -10 -55   -11 600-900  
19:0 -ve PI 297.3 m/z        -100 -10 -55   -11 600-900  
20:5 -ve PI 301.2 m/z        -100 -10 -55   -11 500-900  
20:4 -ve PI 303.2 m/z        -100 -10 -55   -11 600-900  
20:3 -ve PI 305.2 m/z        -100 -10 -55   -11 600-900  
20:2 -ve PI 307.2 m/z        -100 -10 -55   -11 600-900  
20:1 -ve PI 309.2 m/z        -100 -10 -55   -11 600-900  
22:6 -ve PI 327.2 m/z        -100 -10 -55   -11 740-900  
22:5 -ve PI 329.2 m/z        -100 -10 -55   -11 740-900  
22:4 -ve PI 331.2 m/z        -100 -10 -55   -11 740-900  
22:3 -ve PI 333.3 m/z        -100 -10 -55   -11 600-900  
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Table2: Target ion transitions used for GC-MS analysis of sterols in human brain occipital 
cortex. 
Compound 
Target ion transition m/z → m/z 
(Collision energy) 
Squalene  327→ 203 (5) 
(H)14-demthyl-lanosterol 475→ 399 (6) 
14-demthyl-lanosterol 469→ 393 (4) 
(H) Desmosterol 461→ 371 (10) 
Desmosterol 455→ 365 (8) 
(H) Campesterol 474→ 384 (8) 
Campesterol 471→ 381 (8) 
24,25-Dihydrolanosterol 500→ 395 (10) 
Stigmasterol 395→ 255 (5) 
(H) β-Sitosterol 478→ 75 (30) 
β-Sitosterol 471→ 75 (25) 
Lanosterol 483→ 393 (3) 
(H) 24-Hydroxycholesterol 462→ 372 (8) 
24-Hydroxycholesterol 455→ 365 (3) 
(H) 7-Ketocholesterol 480→ 390 (20) 
7-Ketocholesterol 473→ 383 (10) 
(H) 27-Hydroxycholesterol 462→ 161 (15) 






Figure 1: Flowchart comparing lipid extraction methods: “Glass-Chloroform” versus “Bead-
MTBE”; (I.S., internal standards; MTBE, methyl-tert-butyl ether; BHT, butylated 
hydroxytoluene; ESI-MS, electrospray ionisation mass spectrometry; GC-MS, gas 
chromatography-mass spectrometry) 
 
Figure 2: Comparison of ceramide species identified in human occipital cortex using either 
the Bead-MTBE or Glass-Chloroform method. ESI-MS precursor ion scan targeting  
264 m/z for:  a) Bead-MTBE extraction; b) Glass-Chloroform extraction; c) Quantification of 
brain ceramide species using both methods (Bead-MTBE = black bars; Glass-Chloroform = 
grey bars); n = 3 per group; error bars show ± S.E.M. * p < 0.05. 
 
Figure 3: Comparison of sphingomyelin (CerPCho) species identified in human occipital 
cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS precursor ion scan 
targeting 184 m/z for:  a) Bead-MTBE extraction; b) Glass-Chloroform extraction; c) 
Quantification of brain sphingomyelin species using both methods (Bead-MTBE = black 
bars; Glass-Chloroform = grey bars); n = 3 per group; error bars show ± S.E.M.  
 
Figure 4: Comparison of choline glycerophospholipid (ChoGpl) species identified in human 
occipital cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS 
precursor ion scan targeting 184 m/z for:  a) Bead-MTBE extraction; b) Glass-Chloroform 
extraction; c) Quantification of brain choline glycerophospholipid species using both methods 
(Bead-MTBE = black bars; Glass-Chloroform = grey bars); n = 3 per group; error bars show 




Figure 5: Comparison of ethanolamine glycerophospholipid (EtnGpl) species identified in 
human occipital cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS 
neutral loss scan targeting 141 Da for:  a) Bead-MTBE extraction; b) Glass-Chloroform 
extraction; c) Quantification of brain ethanolamine glycerophospholipid species using both 
methods (Bead-MTBE = black bars; Glass-Chloroform = grey bars); n = 3 per group; error 
bars show ± S.E.M.  
 
Figure 6: Comparison of phosphatidylserine (PtdSer) species identified in human occipital 
cortex using either the Bead-MTBE or Glass-Chloroform method. ESI-MS neutral loss scan 
targeting 185 Da for:  a) Bead-MTBE extraction; b) Glass-Chloroform extraction; c) 
Quantification of brain phosphatidylserine species using both methods (Bead-MTBE = black 
bars; Glass-Chloroform = grey bars); n = 3 per group; error bars show ± S.E.M. * p < 0.05. 
 
Figure 7: Comparison of sterol species identified in human occipital cortex using either the 
Bead-MTBE or Glass-Chloroform method. Includes quantification of cholesterol precursors: 
squalene (Squa), lanosterol (Lano), 14-demethyl-lanosterol (14-DL), desmosterol (Desmo), 
24,25-dihydrolanosterol (24,25DHL); oxysterols: 7keto-cholesterol (7KC), 27-
hydroxycholesterol (27OHC), 24-hydroxycholesterol (24OHC); and phytosterols: 
campesterol (Camp), stigmasterol (Stig) and β-sitosterol (βSit); Bead-MTBE = black bars; 
Glass-Chloroform = grey bars; n = 3 per group; error bars show ± S.E.M. 
 
Figure 8: Quantification of human anterior cingulate cortex sphingolipid species; a) 
sphingomyelin; b) ceramide species using both extraction methods (Bead-MTBE = black 
bars; Glass-Chloroform = grey bars); n = 3 different control subjects per group; error bars 
show ± S.E.M. * p < 0.05. 








